SEC Form 4 research
| Issuer | Camp4 Therapeutics Corp |
|---|---|
| Tickers | CAMP |
| Reporting owners | 46 |
| Officers and directors | 6 |
| Last public filing | 2026-09-03 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-02 | 2026-08-31 | Gold Kelly | P | 10,000 | $3.96 | Not reported |
| 2026-08-31 | 2026-08-27 | Schwab Andrew J. | S | 400,000 | $4.04 | Not reported |
| 2026-08-26 | 2026-08-24 | Schwab Andrew J. | S | 10 | $4.5 | Not reported |
| 2026-08-21 | 2026-08-21 | Schwab Andrew J. | S | 32,018 | $4.5 | Not reported |
| 2026-08-21 | 2026-08-20 | Schwab Andrew J. | S | 114,700 | $4.54 | Not reported |
| 2026-08-21 | 2026-08-19 | Schwab Andrew J. | S | 45,147 | $4.76 | Not reported |
| 2026-08-19 | 2026-08-19 | Tardiff Daniel | S | 1,738 | $4.76 | Not reported |
| 2026-08-05 | 2026-08-03 | Young Richard A | P | 16,378 | $1.65 | Not reported |
| 2026-08-05 | 2026-08-03 | Maricich Yuri | P | 6,551 | $1.65 | Not reported |
| 2026-08-05 | 2026-08-03 | Gold Kelly | P | 6,551 | $1.65 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.